Changes in Lipoprotein Subfraction Concentration and Composition in Healthy Individuals Treated With the CETP Inhibitor Anacetrapib

Journal of Lipid Research - United States
doi 10.1194/jlr.m018010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

CETP, LIPC, and SCARB1 Variants in Individuals With Extremely High High-Density Lipoprotein-Cholesterol Levels

Scientific Reports
Multidisciplinary
2019English

Lipoprotein Subfraction Cholesterol Distribution Is Proatherogenic in Women With Type 1 Diabetes and Insulin Resistance

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Increased Concentration of Plasminogen Activator Inhibitor-1 and Fibrinogen in Individuals With Metabolic Syndrome

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2009English

High-Density-Lipoprotein Subfraction 3 Interaction With Glycosylphosphatidylinositol-Anchored Proteins

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1997English

In-Vivo Patellar Tracking in Individuals With Patellofemoral Pain and Healthy Individuals

Journal of Orthopaedic Research
OrthopedicsSports Medicine
2018English

Age-Related Gene and miRNA Expression Changes in Airways of Healthy Individuals

Scientific Reports
Multidisciplinary
2019English

The Changes of Serum Lipoprotein(a) and Plasminogen Activator Inhibitor-1 in Primary Nephrotic Syndrome

International Journal of Sciences
2015English

Energy Substrate Partitioning and Efficiency in Individuals With Atherogenic Lipoprotein Phenotype

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2011English

Mendelian Randomization Reveals Unexpected Effects of CETP on the Lipoprotein Profile

European Journal of Human Genetics
Genetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy